Evidence map›Paper›PMID 32303900›Full record

ArticleWorld journal of urology2021

Radiotherapy plus chemotherapy versus chemotherapy alone in penile cancer patients with extracapsular nodal extension after inguinal lymph node surgery: a multi-institutional study.

Zai-Shang Li, Xue-Ying Li, Bin Wang, Peng Chen, Xiang Li, Ornellas Antonio Augusto, Zi-Ke Qin, Zhuo-Wei Liu, Yong-Hong Li, Hui Han and 1 more

Abstract readComparative StudyMulticenter Study
PubMed Publisher
In one paragraph

Article in World journal of urology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 2 countries.

Zai-Shang Li *Department of Urology, Shenzhen People's Hospital, First Affiliated Hospital of Southern University of Science and Technology, The Second Clinical College of Jinan University, Shenzhen, P. R. China.
Xue-Ying Li *Department of Oncology, The Seventh Affiliated Hospital Sun Yat-Sen University, Shenzhen, Guangdong, P. R. China.
Bin WangDepartment of Urology, Cancer Center of Guangzhou Medical University, Guangzhou, P. R. China.
Peng ChenDepartment of Urology, Affiliated Tumor Hospital of Xinjiang Medical University, Urumchi, P. R. China.
Xiang LiDepartment of Urology, West China Hospital, Chengdu, P. R. China.
Ornellas Antonio AugustoDepartment of Urology, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
Zi-Ke QinDepartment of Urology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, P. R. China.
Zhuo-Wei LiuDepartment of Urology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, P. R. China.
Yong-Hong LiDepartment of Urology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, P. R. China.
Hui HanDepartment of Urology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, P. R. China. hanhui@sysucc.org.cn.
Fang-Jian ZhouDepartment of Urology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, P. R. China. Zhoufj@sysucc.org.cn.
Sun Yat-sen University · CNSouthern Medical University · CNGuangzhou Medical University · CNInstituto Nacional do Câncer · BRSichuan University · CNSun Yat-sen University Cancer Center · CNWest China Hospital of Sichuan University · CNXinjiang Medical University · CN

Funding

National Natural Science Foundation of China 81772755National Natural Science Foundation of China 81902610Shenzhen Health and Family Planning Commission SZLY2018010
6 · The paper itself

Abstract

purposeBecause there is a lack of evidence, it is not generally recommended to use adjuvant radiotherapy plus chemotherapy to treat lymph node disease in penile cancer. The aim of this study was to determine the benefit of using adjuvant radiotherapy after inguinal surgery for penile cancer.

methodsMulti-institutional data were obtained from a total of nine centers from April 2003 to April 2015 and retrospectively analyzed. pN3 patients with an extracapsular nodal extension who received adjuvant therapy after inguinal surgery were included. Cancer-specific survival (CSS) was estimated using the Kaplan-Meier method. The multivariate analysis was performed using a Cox proportional hazards model.

resultsA total of 93 pN3 patients met the inclusion criteria. During the study period, 32 (34.4%) and 61 (65.6%) of these patients received adjuvant radiotherapy plus chemotherapy (AR + AC) or adjuvant chemotherapy alone (AC). The median CSS in all patients was 12.0 months (interquartile range [IQR] 7.5-16.5). The Kaplan-Meier estimated 3-year CSS rate was significantly longer in the AR + AC group (28.5%) than the AC group (16.2%) (p = 0.036). AC + AR was associated with an improvement in CSS by 7.7 months (17.7 [IQR 3.8-31.6] vs. 10.0 [IQR 6.6-13.4] months). In the Cox regression analysis, AR + AC was an independent predictor of CSS [model a: HR 0.486 (95% CI 0.258-0.916), model b: HR 0.527 (95% CI 0.286-0.972)].

conclusionIn conclusions, AR + AC was associated with improved CCS in patients with penile cancer who displayed an extracapsular nodal extension after inguinal surgery. This hypothesis requires further confirmation.

Indexed as

Extranodal ExtensionLymph Node ExcisionAdultAgedHumansInguinal CanalMaleMiddle AgedPenile NeoplasmsRadiotherapy, AdjuvantRetrospective StudiesAdjuvant chemotherapyMortalityNeoplasm metastasisPenile neoplasmsRadiotherapy

Identifiers

PMID32303900
OpenAlexW3017331171

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.